(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BRUKINSA ZANUBRUTINIB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BRUKINSA ZANUBRUTINIB

ST13

US500000088337582

Class

5

Filing

88337582

Registration

6252000

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

68

Latest update

01/20/2026

Trademark type

Combined

Nice classes

5

Filing date

03/13/2019

Registration date

01/19/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/19/2021

Last transaction

01/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/21/2019

First use in commerce

11/21/2019

Drawing code

3

Owner type

16

Owner location

BASEL, CH

Examiner

KHAN,ASMAT A

Law office

M50

Current location

POST REGISTRATION

Mark description

The mark consists of an image of a mountain on the left with the words "BRUKINSA" to the right and the word "ZANUBRUTINIB" below it.

Holders and representatives

Holders

BEONE MEDICINES I GMBH
BG NC 1, LTD.
BEONE MEDICINES LTD.
BeiGene, Ltd.
BeiGene, Ltd.

Representatives

Kristen S. Ruisi VENABLE LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals comprising zanubrutinib for the treatment of cancerautoimmune and inflammatory diseases and infectious diseases

Publications

History of USPTO decisions and trademark events.

68 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/19/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/29/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/10/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/09/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/24/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/24/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/24/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/08/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/08/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/08/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/08/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/08/2022

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

03/04/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/02/2021

ES7R

TEAS SECTION 7 REQUEST RECEIVED

02/03/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/28/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/28/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/28/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/28/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/28/2021

EXPT

EXPARTE APPEAL TERMINATED

01/19/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

01/19/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/18/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/17/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/08/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/08/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

12/02/2020

EXPI

EX PARTE APPEAL-INSTITUTED

12/02/2020

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

12/02/2020

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

12/02/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

06/09/2020

GNFR

FINAL REFUSAL E-MAILED

06/09/2020

CNFR

SU - FINAL REFUSAL - WRITTEN

06/09/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/21/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/21/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/16/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/16/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/16/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/16/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/16/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/16/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/11/2020

GNRT

NON-FINAL ACTION E-MAILED

04/11/2020

CNRT

SU - NON-FINAL ACTION - WRITTEN

04/11/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/23/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/23/2020

IUAF

USE AMENDMENT FILED

03/04/2020

EISU

TEAS STATEMENT OF USE RECEIVED

03/04/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/25/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2019

PUBO

PUBLISHED FOR OPPOSITION

12/31/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2019

ALIE

ASSIGNED TO LIE

11/20/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

11/15/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/15/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

11/15/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/15/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/12/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/12/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/12/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/29/2019

GNRT

NON-FINAL ACTION E-MAILED

05/29/2019

CNRT

NON-FINAL ACTION WRITTEN

05/29/2019

DOCK

ASSIGNED TO EXAMINER

05/22/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/02/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/31/2019

NWAP

NEW APPLICATION ENTERED

03/16/2019

Continuous trademark protection

Get notified about every new filing that threatens BRUKINSA ZANUBRUTINIB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.